nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—SLC6A3—Clearance of dopamine—COMT—conduct disorder	0.178	0.181	CbGpPWpGaD
Modafinil—SLC6A3—Clearance of dopamine—MAOA—conduct disorder	0.177	0.179	CbGpPWpGaD
Modafinil—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0814	0.0824	CbGpPWpGaD
Modafinil—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0808	0.0818	CbGpPWpGaD
Modafinil—SLC6A3—Monoamine Transport—SLC6A4—conduct disorder	0.0354	0.0359	CbGpPWpGaD
Modafinil—ADRA1B—Monoamine GPCRs—DRD4—conduct disorder	0.0283	0.0287	CbGpPWpGaD
Modafinil—CYP1A2—Methylation—COMT—conduct disorder	0.027	0.0274	CbGpPWpGaD
Modafinil—ADRA1B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0238	0.0241	CbGpPWpGaD
Modafinil—ADRA1B—Monoamine GPCRs—HTR2A—conduct disorder	0.0185	0.0187	CbGpPWpGaD
Modafinil—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.0169	0.0171	CbGpPWpGaD
Modafinil—ADRA1B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0155	0.0157	CbGpPWpGaD
Modafinil—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.0147	0.0149	CbGpPWpGaD
Modafinil—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.013	0.0132	CbGpPWpGaD
Modafinil—SLC6A3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0129	0.013	CbGpPWpGaD
Modafinil—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.0114	0.0116	CbGpPWpGaD
Modafinil—SLC6A3—NRF2 pathway—SLC6A4—conduct disorder	0.0105	0.0107	CbGpPWpGaD
Modafinil—SLC6A3—Neuronal System—GABRA2—conduct disorder	0.00986	0.00999	CbGpPWpGaD
Modafinil—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00881	0.00892	CbGpPWpGaD
Modafinil—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00861	0.00872	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00835	0.00846	CbGpPWpGaD
Modafinil—Atomoxetine—SLC6A4—conduct disorder	0.00727	0.566	CrCbGaD
Modafinil—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00665	0.00674	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CGA—conduct disorder	0.00636	0.00644	CbGpPWpGaD
Modafinil—SLC6A3—Transmission across Chemical Synapses—COMT—conduct disorder	0.00619	0.00628	CbGpPWpGaD
Modafinil—SLC6A3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00615	0.00623	CbGpPWpGaD
Modafinil—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00607	0.00615	CbGpPWpGaD
Modafinil—Atomoxetine—HTR2A—conduct disorder	0.00559	0.435	CrCbGaD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00546	0.00553	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0053	0.00537	CbGpPWpGaD
Modafinil—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00518	0.00525	CbGpPWpGaD
Modafinil—SLC6A3—Neuronal System—COMT—conduct disorder	0.00475	0.00481	CbGpPWpGaD
Modafinil—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00474	0.0048	CbGpPWpGaD
Modafinil—SLC6A3—Neuronal System—MAOA—conduct disorder	0.00471	0.00477	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—COMT—conduct disorder	0.00471	0.00477	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00468	0.00474	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00468	0.00474	CbGpPWpGaD
Modafinil—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.00465	0.00471	CbGpPWpGaD
Modafinil—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.00461	0.00467	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—COMT—conduct disorder	0.0046	0.00466	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00457	0.00463	CbGpPWpGaD
Modafinil—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00454	0.0046	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00412	0.00418	CbGpPWpGaD
Modafinil—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.004	0.00405	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.0036	0.00364	CbGpPWpGaD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00356	0.00361	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.00356	0.00361	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00356	0.00361	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.00353	0.00358	CbGpPWpGaD
Modafinil—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00351	0.00356	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00342	0.00346	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00342	0.00346	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.00326	0.00331	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00325	0.00329	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00322	0.00326	CbGpPWpGaD
Modafinil—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.0032	0.00324	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00305	0.00309	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00303	0.00307	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00277	0.00281	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00276	0.0028	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00275	0.00279	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00274	0.00277	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00236	0.00239	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	0.00232	0.00235	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00214	0.00217	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00213	0.00215	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00211	0.00214	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	0.00201	0.00204	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CGA—conduct disorder	0.00193	0.00195	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	0.00183	0.00185	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CGA—conduct disorder	0.00178	0.00181	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CGA—conduct disorder	0.00174	0.00177	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—WASF1—conduct disorder	0.00155	0.00157	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CGA—conduct disorder	0.00135	0.00137	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	0.00131	0.00133	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CGA—conduct disorder	0.00123	0.00125	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	0.00119	0.00121	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—DRD4—conduct disorder	0.00108	0.00109	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CGA—conduct disorder	0.00105	0.00106	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CGA—conduct disorder	0.000811	0.000822	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—COMT—conduct disorder	0.000806	0.000816	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—MAOA—conduct disorder	0.0008	0.00081	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—COMT—conduct disorder	0.000787	0.000798	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—MAOA—conduct disorder	0.000782	0.000792	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	0.000705	0.000714	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—COMT—conduct disorder	0.000609	0.000617	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—MAOA—conduct disorder	0.000604	0.000612	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000586	0.000594	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—COMT—conduct disorder	0.000555	0.000562	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—MAOA—conduct disorder	0.000551	0.000558	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000534	0.000541	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—COMT—conduct disorder	0.000474	0.00048	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MAOA—conduct disorder	0.000471	0.000477	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000457	0.000463	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EP300—conduct disorder	0.000373	0.000378	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—COMT—conduct disorder	0.000366	0.000371	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MAOA—conduct disorder	0.000363	0.000368	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—EP300—conduct disorder	0.000345	0.00035	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—EP300—conduct disorder	0.000338	0.000342	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—EP300—conduct disorder	0.000261	0.000264	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—EP300—conduct disorder	0.000238	0.000241	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—EP300—conduct disorder	0.000203	0.000206	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—EP300—conduct disorder	0.000157	0.000159	CbGpPWpGaD
